Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 172

Similar articles for PubMed (Select 23875831)

1.

The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis.

Semba T, Nishimura M, Nishimura S, Ohara O, Ishige T, Ohno S, Nonaka K, Sogawa K, Satoh M, Sawai S, Matsushita K, Imazeki F, Yokosuka O, Nomura F.

BMC Gastroenterol. 2013 Jul 23;13:120. doi: 10.1186/1471-230X-13-120.

2.

Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.

Auguet T, Terra X, Quintero Y, Martínez S, Manresa N, Porras JA, Aguilar C, Orellana-Gavaldà JM, Hernández M, Sabench F, Lucas A, Pellitero S, Del Castillo D, Richart C.

Exp Clin Endocrinol Diabetes. 2013 Feb;121(2):119-24. doi: 10.1055/s-0032-1331696. Epub 2013 Feb 20.

PMID:
23426707
3.

Molecular interplay between Δ5/Δ6 desaturases and long-chain fatty acids in the pathogenesis of non-alcoholic steatohepatitis.

López-Vicario C, González-Périz A, Rius B, Morán-Salvador E, García-Alonso V, Lozano JJ, Bataller R, Cofán M, Kang JX, Arroyo V, Clària J, Titos E.

Gut. 2014 Feb;63(2):344-55. doi: 10.1136/gutjnl-2012-303179. Epub 2013 Mar 14.

PMID:
23492103
4.

Protective effects of lipocalin-2 (LCN2) in acute liver injury suggest a novel function in liver homeostasis.

Borkham-Kamphorst E, van de Leur E, Zimmermann HW, Karlmark KR, Tihaa L, Haas U, Tacke F, Berger T, Mak TW, Weiskirchen R.

Biochim Biophys Acta. 2013 May;1832(5):660-73. doi: 10.1016/j.bbadis.2013.01.014. Epub 2013 Jan 31.

5.

Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.

Shindo N, Fujisawa T, Sugimoto K, Nojima K, Oze-Fukai A, Yoshikawa Y, Wang X, Yasuda O, Ikegami H, Rakugi H.

J Hepatol. 2010 Jun;52(6):903-12. doi: 10.1016/j.jhep.2009.12.033. Epub 2010 Mar 24.

PMID:
20392512
6.

The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease.

Lake AD, Novak P, Hardwick RN, Flores-Keown B, Zhao F, Klimecki WT, Cherrington NJ.

Toxicol Sci. 2014 Jan;137(1):26-35. doi: 10.1093/toxsci/kft230. Epub 2013 Oct 4.

7.
8.

Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.

Borkham-Kamphorst E, Drews F, Weiskirchen R.

Liver Int. 2011 May;31(5):656-65. doi: 10.1111/j.1478-3231.2011.02495.x. Epub 2011 Mar 16.

PMID:
21457438
9.

Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition.

Ko GJ, Grigoryev DN, Linfert D, Jang HR, Watkins T, Cheadle C, Racusen L, Rabb H.

Am J Physiol Renal Physiol. 2010 Jun;298(6):F1472-83. doi: 10.1152/ajprenal.00619.2009. Epub 2010 Feb 24.

10.

Extracellular matrix and cytochrome P450 gene expression can distinguish steatohepatitis from steatosis in mice.

Hennig EE, Mikula M, Goryca K, Paziewska A, Ledwon J, Nesteruk M, Woszczynski M, Walewska-Zielecka B, Pysniak K, Ostrowski J.

J Cell Mol Med. 2014 Sep;18(9):1762-72. doi: 10.1111/jcmm.12328. Epub 2014 Jun 9.

11.

The roles of lipocalin-2 in small-for-size fatty liver graft injury.

Cheng Q, Ng KT, Xu A, Li CX, Liu XB, Guo DY, Poon RT, Fan ST, Lo CM, Man K.

Ann Surg. 2014 Dec;260(6):1062-72. doi: 10.1097/SLA.0000000000000427.

PMID:
24374540
12.

Proteomic profiling in Lipocalin 2 deficient mice under normal and inflammatory conditions.

Labbus K, Henning M, Borkham-Kamphorst E, Geisler C, Berger T, Mak TW, Knüchel R, Meyer HE, Weiskirchen R, Henkel C.

J Proteomics. 2013 Jan 14;78:188-96. doi: 10.1016/j.jprot.2012.11.021. Epub 2012 Dec 3.

PMID:
23219901
13.

Expression of fatty acid synthase in nonalcoholic fatty liver disease.

Dorn C, Riener MO, Kirovski G, Saugspier M, Steib K, Weiss TS, Gäbele E, Kristiansen G, Hartmann A, Hellerbrand C.

Int J Clin Exp Pathol. 2010 Mar 25;3(5):505-14.

14.

Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.

Tang Y, Bian Z, Zhao L, Liu Y, Liang S, Wang Q, Han X, Peng Y, Chen X, Shen L, Qiu D, Li Z, Ma X.

Clin Exp Immunol. 2011 Nov;166(2):281-90. doi: 10.1111/j.1365-2249.2011.04471.x.

15.

Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis.

Gao Y, Song LX, Jiang MN, Ge GY, Jia YJ.

Inflammation. 2008 Apr;31(2):121-32. doi: 10.1007/s10753-008-9057-3. Epub 2008 Feb 27.

PMID:
18302012
16.

Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis.

Younossi ZM, Gorreta F, Ong JP, Schlauch K, Del Giacco L, Elariny H, Van Meter A, Younoszai A, Goodman Z, Baranova A, Christensen A, Grant G, Chandhoke V.

Liver Int. 2005 Aug;25(4):760-71.

PMID:
15998427
17.

p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.

Tomita K, Teratani T, Suzuki T, Oshikawa T, Yokoyama H, Shimamura K, Nishiyama K, Mataki N, Irie R, Minamino T, Okada Y, Kurihara C, Ebinuma H, Saito H, Shimizu I, Yoshida Y, Hokari R, Sugiyama K, Hatsuse K, Yamamoto J, Kanai T, Miura S, Hibi T.

J Hepatol. 2012 Oct;57(4):837-43. doi: 10.1016/j.jhep.2012.05.013. Epub 2012 May 26.

PMID:
22641095
18.

Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.

Shiri-Sverdlov R, Wouters K, van Gorp PJ, Gijbels MJ, Noel B, Buffat L, Staels B, Maeda N, van Bilsen M, Hofker MH.

J Hepatol. 2006 Apr;44(4):732-41. Epub 2005 Dec 20.

PMID:
16466828
19.

Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.

Miquilena-Colina ME, Lima-Cabello E, Sánchez-Campos S, García-Mediavilla MV, Fernández-Bermejo M, Lozano-Rodríguez T, Vargas-Castrillón J, Buqué X, Ochoa B, Aspichueta P, González-Gallego J, García-Monzón C.

Gut. 2011 Oct;60(10):1394-402. doi: 10.1136/gut.2010.222844. Epub 2011 Jan 26.

PMID:
21270117
20.

High sensitivity of fatty liver Shionogi (FLS) mice to diethylnitrosamine hepatocarcinogenesis: comparison to C3H and C57 mice.

Iwai S, Murai T, Makino S, Min W, Morimura K, Mori S, Hagihara A, Seki S, Fukushima S.

Cancer Lett. 2007 Feb 8;246(1-2):115-21. Epub 2006 Mar 29.

PMID:
16569478
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk